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Abstract
Background: To evaluate the association between prepregnancy body mass index (BMI) is associated with early vs.
late and medically-induced vs. spontaneous preterm birth (PTB) subtypes.
Methods: Using data from the Boston Birth Cohort, we examined associations of prepregnancy BMI with 189 early
(<34 completed weeks) and 277 late (34–36 completed weeks) medically-induced PTBs and 320 early and 610
late spontaneous PTBs vs. 3281 term births (37–44 weeks) in multinomial regression. To assess for mediation by
important pregnancy complications, we performed sequential models with and without hypertensive disorders of
pregnancy, chorioamnionitis, and gestational diabetes.
Results: Prevalence of prepregnancy obesity (BMI ≥ 30.0 kg/m
2) was 28% among mothers with medically-induced
PTBs, 18% among mothers with spontaneous PTBs, and 18% among mothers with term births (p =<0.001). After
adjustment for demographic and known risk factors for PTB, prepregnancy obesity was associated with higher
odds of both early [OR 1.78 (1.19, 2.66)] and late [OR 1.49 (1.09, 2.04)] medically-induced PTB. These effect estimates
were attenuated with inclusion of hypertensive disorders of pregnancy and gestational diabetes. For spontaneous
deliveries, prepregnancy obesity was associated with decreased odds of PTB (0.76 [0.58, 0.98]) and underweight
was nearly associated with increased odds of PTB (1.46 [0.99, 2.16]).
Conclusion: Prepregnancy obesity is associated with higher risk of medically-induced, but not spontaneous PTB.
Hypertensive disorders of pregnancy and gestational diabetes appear to partially explain the association between
prepregnancy obesity and early and late medically-induced PTB.
Keywords: Maternal obesity, Prepregnancy BMI, Medically-induced preterm birth, Spontaneous preterm birth, Late
preterm birth
Background
In the context of the national obesity epidemic, 1 in 5
pregnant women in the US is obese [1]. Pregnancies
among obese women are considered high-risk because
they are associated with maternal morbidities including
hypertensive and thromboembolic disorders, infection,
and gestational diabetes [2]. Concurrent with the rise in
obesity prevalence, the rate of preterm birth (PTB) has
increased in the past two decades, such that over 12% of
infants born in the US are preterm [3]. PTB is the lead-
ing cause of neonatal mortality and childhood morbidity,
affects over 500,000 infants and costs the US more than
$26 billion annually [4,5].
PTB is a heterogeneous condition. PTB can occur spon-
taneously following preterm labor or premature rupture
of membranes or for medical indications. Furthermore,
PTB can occur “early” (<34 weeks’ gestation) or “late”
(34–36 weeks’gestation). Pregnancy complications leading
to medical inductions disproportionately contribute to late
PTB, as compared to early PTB [6-8]. A recent systematic
review of 84 studies demonstrated that prepregnancy
obesity is associated with a 1.24-fold increased risk of PTB
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ity with PTB are unclear. Differentiating spontaneous
from medically-induced PTB and early from late PTB may
offer important clues to understanding the link between
prepregnancy obesity and PTB.
Specific complications of pregnancy that occur in obese
women may lead to PTB. For example, severe hypertensive
disorders of pregnancy are common among obese women,
and represent one of the most frequent medical indications
for preterm delivery [2]. Spontaneous preterm labor or
rupture of membranes is more likely to occur among
women with chorioamnionitis [10,11], a condition found
more often in obese women compared to normal weight
women [12]. Additionally, some evidence suggests that
gestational diabetes, another common condition among
obese women [2], is associated with medically-induced [13]
and spontaneous [13,14] preterm delivery. These findings
all suggest potential mechanisms linking prepregnancy
obesity with PTB, but few studies have specifically exam-
ined the extent to which these conditions mediate ob-
served associations. Additionally, little is known about the
relationship of these conditions, and prepregnancy obesity
itself, with early versus late PTB, which could also shed
light on underlying mechanisms. Our objectives were: (1)
to determine the extent to which prepregnancy body mass
index (BMI) is associated with early and late medically-
induced and spontaneous PTB and (2) to examine the
extent to which these relationships are mediated by
pregnancy complications related to prepregnancy obesity,
specifically hypertensive disorders of pregnancy, chor-
ioamnionitis, and gestational diabetes.
Methods
Study population
We studied participants in the Boston Birth Cohort.
Briefly, the Boston Birth Cohort is a case–control study
designed to evaluate adverse birth outcomes, particularly
PTB and intrauterine fetal growth restriction [15]. Be-
ginning in 1998, women have been recruited that are
admitted to the Labor and Delivery floor at Boston
Medical Center, an inner-city hospital serving predomin-
ately minority populations with Medicaid insurance
in Boston, Massachusetts. Women have been recruited
who delivered a singleton live infant, vaginally or by
cesarean section, and meet the definition of a case (ges-
tational age <37 weeks or birth weight <2,500 grams) or
control (gestational age ≥ 37 completed weeks and birth
weight ≥ 2,500 grams). Controls were matched by mater-
nal age and race to cases in a 2:1 ratio. Mother-infant
pairs are recruited 24 to 72 hours postpartum. Multiple
gestation pregnancies, pregnancies resulting from in-
vitro fertilization, deliveries resulting from maternal
trauma, and infants born <23 completed weeks gestation
(non-viable) or with major birth defects are excluded.
More than 90% of mother-infant pairs approached for
study participation enrolled in the study. Recruitment is
ongoing. The institutional review board provided ethical
approval for this study at Boston Medical Center.
After obtaining written informed consent, mothers are
interviewed 24 to 72 hours postpartum using a standard-
ized questionnaire (Additional file 1). A standardized ab-
straction form is used to obtain clinical data from maternal
and infant records, including prenatal care, ultrasound find-
ings, laboratory reports, pregnancy complications, labor
and delivery course, and birth outcomes (infant gender, ges-
tational age, and birth weight and length).
For this analysis, we used mother-infant pairs enrolled
from 1998 to 2008. We combined infants born 37–44
completed weeks that are<2,500 grams (low birth weight,
term “cases,” N=375) and≥2,500 grams (non-low birth
weight, term “controls,” N=2906) to make up our refer-
ence group of 3281 term infants. We compared term in-
fants to 1396 preterm infants born at<37 completed
weeks. Of the 1396 preterm cases, we further separated
this group into medically-induced (N=466) and spontan-
eous (N=930) PTBs, and according to gestational age at
birth (early [<34 completed weeks] and late [34–36 com-
pleted weeks] PTBs) in our analyses (Figure 1).
Main predictor: prepregnancy BMI
Based on maternal self-report of prepregnancy weight
and height, we categorized maternal underweight, over-
weight, and obesity per Institute of Medicine Criteria
(IOM) [16] as BMI <18.0 kg/m
2, 25.0-29.9 kg/m
2 and
BMI ≥ 30.0 kg/m
2, respectively. Our reference group was
normal weight (BMI 18.0-24.9 kg/m
2).
Main outcome: PTB
Our main outcome was PTB, categorized by: 1) Delivery
type [17], defined as spontaneous (birth to a mother
who presented with uterine contractions and/or rupture
of membranes) or medically-induced (birth to a mother
who presented without uterine contractions or rupture
of membranes prior to delivery). Report of maternal
presentation prior to delivery was abstracted from the
medical record; and 2) Gestational age at the time of de-
livery, defined as early (<34 completed weeks) or late
(34–36 completed weeks) PTB. Gestational age at deliv-
ery was determined by maternal report of last menstrual
period (LMP) and early fetal ultrasound (<20 weeks).
When the ultrasound estimate of gestational age differed
by >7 days than the gestational age predicted by mater-
nal report of LMP, the ultrasound assessment was used.
Clinical report of physical exam findings by the attend-
ing physician or nurse practitioner was used to estimate
gestational age in conjunction with Dubowitz/Ballard
Score [18] when no LMP or ultrasound prediction of
gestational age was available (N =12).
Parker et al. BMC Pregnancy and Childbirth 2014, 14:153 Page 2 of 10
http://www.biomedcentral.com/1471-2393/14/153Potential mediators of prepregnancy BMI and PTB
Hypertensive disorders of pregnancy
We used clinical blood pressure (BP) measurements and
laboratory findings that were abstracted from the maternal
medical record before and during pregnancy. We catego-
rized hypertensive disorders of pregnancy according to
established guidelines [19,20] as: 1) Chronic hypertension,
defined as elevated BP<20 weeks gestation of the index
pregnancy or a clinical diagnosis prior to pregnancy; 2)
Mild preeclampsia; 3) Severe hypertensive disorders of
pregnancy (severe preeclampsia, eclampsia, and HELLP
syndrome; and 4) Normal blood pressure.
Chorioamnionitis
We categorized chorioamnionitis based on report of clin-
ical signs and symptoms during labor, as well as placental
pathology reports, into the following groups: 1) Clinical
chorioamnionitis, defined as maternal temperature>38°C
within 24 hours of delivery in addition to two of the fol-
lowing: uterine tenderness, foul smelling vaginal discharge
or amniotic fluid, maternal heart rate >100 beats per mi-
nute, fetal heart rate >160 beats per minute, maternal
white blood cell count >15,000 cells per cubic liter [21], or
placental pathology report of chorioamnionitis; 2) Subclin-
ical chorioamnionitis, defined as any single clinical symp-
tom or sign mentioned above. We created this additional
category to test the hypothesis that mild infection may
also contribute to PTB; and 3) No chorioamnionitis, de-
fined as none of the symptoms or signs listed above.
Gestational diabetes
As a part of clinical care, pregnant women underwent
screening for gestational diabetes with an oral non-
fasting glucose challenge test and/or fasting glucose tol-
erance test at 24–28 completed weeks gestation. We
formed 3 categories for our analysis: 1) Gestational dia-
betes; 2) Pre-existing diabetes mellitus (diagnosis prior
to 24 weeks gestation of index pregnancy); and 3) No
diabetes mellitus. We combined gestational diabetes and
diabetes mellitus for multivariate analyses due to small
sample sizes in each category.
Other covariates
Infant sex and birth weight, parity, glucose tolerance,
presence of cervical incompetence, and placenta previa
were abstracted from the medical record. Report of ma-
ternal age, marital status, household income, education
level, race/ethnicity, smoking, alcohol and drug use,
and stress were obtained during the maternal interview.
We calculated gestational weight gain as the difference
between the last recorded weight before delivery and
the self-reported prepregnancy weight. We categorized
women as having gained inadequate, adequate, or exces-
sive weight by week of pregnancy according to the 2009
Institute of Medicine guidelines (0.5-2 kg for the first tri-
mester for all women plus 0.42 kg/week for normal
weight women, 0.28 kg/week for overweight women and
0.22 kg/week for obese women in the second and third
trimester) [16]. For women who delivered preterm, we
determined category of gestational weight gain according
to guidelines for the completed week of gestation that
delivery occurred.
Statistical analysis
First we examined bivariate relationships among our main
predictor, outcomes, mediators, and other covariates using
ANOVA for continuous variables and chi-square tests
for categorical variables (Table 1). After testing model
assumptions, we first used linear regression to examine
the association of prepregancy BMI and gestational weeks
at delivery as a continuous variable. Next we used logistic
regression to examine odds of PTB vs. term birth accord-
ing to prepregnancy BMI (Table 2). Then we used multi-
nomial regression to examine odds of medically-induced
and spontaneous PTB vs. term birth according to prepreg-
nancy BMI in the same model (Table 2). Finally, also using
multinomial regression, we examined odds of early and
late medically-induced and early and late spontaneous
PTB vs. term birth according to prepregnancy BMI
(Table 3). The references group for all models was pre-
pregnancy normal weight.
Model 1 included prepregnancy BMI only. Model 2
additionally included demographic variables (maternal
3281 Term Births
(≥ 37 weeks)
1396 PTBs 
(< 37 weeks)
189 Early Medically-induced 
PTBs (< 34 weeks)
277 Late Medically-induced 
PTBs (34-36 weeks)
320 Early Spontaneous 
PTBs (< 34 weeks)
610 Late Spontaneous 
PTBs (34-36 weeks)
466 Medically-induced PTBs 930 Spontaneous PTBs 
Figure 1 Participant inclusion criteria.
Parker et al. BMC Pregnancy and Childbirth 2014, 14:153 Page 3 of 10
http://www.biomedcentral.com/1471-2393/14/153Table 1 Characteristics of Mother-Infant pairs according to delivery type
Medically-induced PTBs
a Spontaneous PTBs
a Term births
b p-value
c
(N=466) (N=930) (N=3281)
Mean (SD)
Maternal age (years) 29.5 (6.8) 28.0 (6.6) 27.8 (6.4) <0.001
Gestational age at birth (weeks) 33.7 (3.0) 33.7 (3.4) 39.5 (1.3) <0.001
Prepregnancy BMI (kg/m
2) 27.1 (6.6) 25.5 (6.0) 25.8 (6.1) <0.001
Birth weight (grams) 1989 (734) 2237 (716) 3239 (563) <0.001
N (%)
Prepregnancy BMI (kg/m
2)
<0.001
<18.5 13 (2.8) 54 (5.8) 149 (4.5)
18.5-24.9 188 (40.3) 444 (47.7) 1613 (49.2)
25.0-29.9 136 (29.2) 269 (28.9) 915 (27.9)
≥ 30.0 129 (27.7) 163 (17.5) 604 (18.4)
Hypertensive disorders of pregnancy
<0.001
None 179 (38.7) 850 (92.1) 3004 (92.2)
Chronic hypertension 19 (4.1) 27 (2.9) 71 (2.2)
Mild preeclampsia 60 (13.0) 24 (2.6) 123 (3.8)
Severe hypertensive disorders (severe pre-eclampsia,
eclampsia, HELLP syndrome)
205 (44.3) 22 (2.4) 61 (1.9)
Chorioamnionitis
<0.001
None 125 (26.8) 252 (27.1) 1265 (38.6)
Subclinical chorioamnionitis 117 (25.1) 157 (16.9) 578 (17.6)
Clinical chorioamnionitis 35 (7.5) 239 (25.7) 302 (9.2)
Unknown 189 (40.6) 282 (30.3) 1136 (34.6)
Glucose tolerance
<0.001
No 401 (86.4) 855 (92.3) 3090 (94.5)
Gestational diabetes 39 (8.4) 46 (5.0) 145 (4.4)
Diabetes mellitus before index pregnancy 24 (5.2) 25 (2.7) 35 (1.1)
Gestational weight gain per 2009 IOM
<0.001
Inadequate 50 (10.7) 118 (12.7) 479 (14.6)
Adequate 38 (8.2) 115 (12.4) 635 (19.4)
Excessive 148 (31.8) 306 (32.9) 853 (26.0)
Unknown 230 (49.4) 391 (42.0) 1314 (40.0)
Married 159 (34.2) 250 (26.9) 1183 (36.2) <0.001
Household income
0.13
< $30,000/yr 213 (45.7) 475 (51.1) 1580 (48.2)
≥ $30,000/yr 69 (14.8) 100 (10.8) 387 (11.8)
Unknown 184 (39.5) 355 (38.2) 1314 (40.0)
Education
0.02
< High school 138 (29.6) 310 (33.3) 1100 (33.5)
High school 176 (37.8) 336 (36.1) 1055 (32.2)
> High school 152 (32.6) 284 (30.5) 1126 (34.3)
Maternal race/ethnicity
0.003 White 52 (11.2) 130 (14.0) 342 (10.4)
Black 260 (55.8) 482 (51.8) 1646 (50.2)
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child sex) and variables that are associated with PTB
[10] (maternal smoking, alcohol and drug use, stress,
cervical incompetence, placental previa, and gestational
weight gain). In Model 3–5, we sequentially added
hypertensive disorders of pregnancy, chorioamnionitis,
and gestational diabetes to examine potential mediating
effects of these variables on the relationship between
prepregnancy BMI and PTB. In Model 5, we included all
covariates and mediators to assess if the combination of
these factors changes the main associations. We per-
formed data analysis with SAS 9.3 (SAS Institute, Cary,
North Carolina).
Results
Participant characteristics are shown in Table 1. Among
1396 PTBs, 466 (33%) were medically-induced PTBs
and 930 (67%) were spontaneous PTBs. Prevalence of
prepregnancy obesity was 28% among mothers with
medically-induced PTBs, 18% among mothers with
spontaneous PTBs, and 18% among mothers with term
births (Table 1). Severe hypertensive disorders of preg-
nancy and gestational diabetes were most prevalent
among mothers with medically-induced PTBs (44% and
8%), compared to mothers with spontaneous PTBs (2%
and 5%), and term births (2% and 4%). Clinical chor-
ioamnionitis was most prevalent among mothers of
spontaneous PTBs (30%), compared to mothers with
medically-induced PTBs (8%), and term births (9%)
(Table 1).
After adjusting for demographic variables and con-
founders, we found that, among all subjects, mothers
with prepregnancy obesity delivered infants 0.28 weeks
(95% C.I. [−0.54 to −0.03]) earlier than mothers with
prepregnancy normal weight (data not shown). We found
that this relationship was attenuated when hypertensive
Table 1 Characteristics of Mother-Infant pairs according to delivery type (Continued)
Hispanic 106 (22.7) 213 (22.9) 892 (27.2)
Other 48 (10.3) 105 (11.3) 401 (12.2)
Maternal smoking 3 months before or during index pregnancy 98 (21.0) 275 (29.6) 591(18.0) <0.001
Maternal stress during pregnancy
<0.001
No stress 144 (31.1) 304 (33.1) 1269 (38.9)
Average stress 194 (41.9) 396 (43.1) 1385 (42.4)
Very stressful 125 (27.0) 218 (23.7) 612 (18.7)
Any illicit drug use during pregnancy 76 (16.5) 218 (23.5) 432 (13.2) <0.001
Alcohol use during pregnancy 30 (6.5) 65 (7.0) 211 (6.4) 0.84
Parity
0.02
Nulliparous 207 (44.4) 385 (41.4) 1381 (42.1)
Primiparous 119 (25.5) 239 (25.7) 977 (29.8)
Multiparous 140 (30.0) 306 (32.9) 923 (28.1)
Cervical incompetence 16 (3.4) 64 (6.9) 37 (1.1) <0.001
Placenta previa 22 (4.7) 29 (3.1) 32 (1.0) <0.001
Preterm premature rupture of membranes 0 (0.0) 439 (47.2) 0 (0.0) N/A
Mode of delivery
<0.001 Vaginal 136 (29.2) 695 (74.8) 2302 (70.2)
Cesarean section 330 (70.8) 234 (25.2) 977 (29.8)
Delivery type
N/A Medically-induced 466 (100.0) 0 (0.0) 971 (29.6)
Spontaneous 0 (0.0) 930 (100.0) 2310 (70.4)
PTB according to gestational age
N/A N/A Early PTB (<34 weeks) 189 (40.6) 320 (34.4)
Late PTB (34–36 weeks) 277 (59.4) 610 (65.6)
Infant sex- female 247 (53.0) 447 (48.1) 1656 (50.5) 0.20
PTB = Preterm Birth; BMI = Body Mass Index; IOM = Institute of Medicine; HELLP= hemolysis, elevated liver enzymes, low platelets.
aPTBs include births at 23–36 weeks gestation.
bTerm Births include births at 37–44 weeks gestation.
cP-values calculated from chi-square tests for categorical variables and ANOVA for continuous variables.
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(−0.28 to −0.17), but not when chorioamnionitis (−0.28 to
−0.30) was added to our model (data not shown). We
found no associations between prepregnancy BMI and all
subtypes of PTB (OR 1.11 [0.93, 1.33]) (Table 2, Model 2).
When we examined medically-induced and spontaneous
Table 2 Odds of medically-induced, spontaneous, and All PTB compared with term birth according to
prepregnancy BMI
a
Medically-induced PTB
b Spontaneous PTB
b All PTB
c
Crude and adjusted models OR 95% C.I. p-value OR 95% C.I. p-value OR 95% C.I. p-value
M1: Unadjusted
< 18.5 0.75 0.42, 1.35 0.33 1.32 0.95, 1.83 0.10 1.15 0.85, 1.55 0.37
18.5-24.9 (ref) 1.00 1.00 1.00
25.0-29.9 1.28 1.01, 1.61 0.04 1.07 0.90, 1.27 0.45 1.13 0.97, 1.31 0.11
≥ 30.0 1.83 1.44, 2.34 <0.001 0.98 0.80, 1.20 0.85 1.23 1.04, 1.46 0.01
M2: Adjusted
d
<18.5 0.94 0.52, 1.71 0.84 1.40 0.99, 1.99 0.06 1.29 0.94, 1.77 0.12
18.5-24.9 (ref) 1.00 1.00 1.00
25.0-29.9 1.11 0.87, 1.43 0.39 0.99 0.82, 1.18 0.87 1.02 0.87, 1.20 0.79
≥ 30.0 1.59 1.23, 2.05 <0.001 0.90 0.73, 1.12 0.35 1.11 0.93, 1.33 0.25
Models to further assess mediation
M3: M2+ hypertensive disorders of pregnancy
e
<18.5 1.19 0.60, 2.34 0.62 1.41 1.00, 2.00 0.05 1.38 0.99, 1.91 0.05
18.5-24.9 (ref) 1.00 1.00 1.00
25.0-29.9 0.96 0.72, 1.29 0.81 0.98 0.81, 1.17 0.80 0.97 0.83, 1.15 0.76
≥ 30.0 1.13 0.82, 1.54 0.46 0.91 0.73, 1.13 0.40 0.97 0.80, 1.17 0.73
M4: M2+ chorioamnionitis
f
<18.5 0.93 0.51, 1.69 0.81 1.48 1.04, 2.10 0.03 1.32 0.96, 1.82 0.09
18.5-24.9 (ref) 1.00 1.00 1.00
25.0-29.9 1.12 0.87, 1.43 0.39 0.99 0.83, 1.20 0.95 1.03 0.88, 1.21 0.73
≥ 30.0 1.58 1.22, 2.05 0.001 0.91 0.73, 1.12 0.37 1.12 0.93, 1.34 0.23
M5: M2+ gestational diabetes
f
<18.5 0.96 0.53, 1.75 0.90 1.42 1.00, 2.01 0.05 1.31 0.95, 1.80 0.10
18.5-24.9 (ref) 1.00 1.00 1.00
25.0-29.9 1.06 0.82, 1.36 0.66 0.96 0.79, 1.15 0.63 0.98 0.84, 1.15 0.83
≥ 30.0 1.40 1.08, 1.83 0.01 0.86 0.69, 1.07 0.16 1.03 0.85, 1.23 0.78
Grand model
M6: M2+ hypertensive disorders of pregnancy
e +
chorioamnionitis
f +gestational diabetes
g
<18.5 1.21 0.61, 2.39 0.58 1.51 1.06, 2.15 0.02 1.45 1.04, 2.02 0.03
18.5-24.9 (ref) 1.00 1.00 1.00
25.0-29.9 0.94 0.70, 1.27 0.69 0.95 0.79, 1.15 0.60 0.95 0.80, 1.12 0.54
≥ 30.0 1.08 0.78, 1.49 0.65 0.86 0.69, 1.07 0.17 0.92 0.75, 1.11 0.38
BMI = Body Mass Index; PTB = Preterm Birth.
aData from 466 mothers with medically-induced PTBs, 930 mothers with spontaneous PTBs, and 3281 mothers with term births.
bMultinomial regression used to compare medically-induced and spontaneous PTB with term birth (reference group).
cLogistic regression used to compare all PTB with term birth (reference group).
dAdjusted model includes maternal age, race/ethnicity, marital status, income, education, child sex, maternal gestational weight gain, smoking, alcohol or illicit
drug use, stress, parity, cervical incompetence, and placenta previa.
eHypertensive disorders of pregnancy are categorized as chronic hypertension, mild preeclampsia, severe hypertensive disorders (severe preeclampsia, eclampsia,
HELLP syndrome), and none.
fChorioamnionitis is categorized as subclinical chorioamnionitis, clinical chorioamnionitis, and none.
gMaternal diabetes is categorized as gestational diabetes or diabetes prior to pregnancy vs. none.
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prepregnancy BMI
a,b
Early medically-induced PTB Late medically-induced PTB Early spontaneous PTB Late spontaneous PTB
Crude and adjusted models OR 95% C.I. p-value OR 95% C.I. p-value OR 95% C.I. p-value OR 95% C.I. p-value
M1: Unadjusted
< 18.5 0.33 0.08, 1.37 0.13 0.97 0.51, 1.83 0.92 1.30 0.76, 2.20 0.34 1.33 0.91, 1.94 0.15
18.5-24.9 (ref) 1.00 1.00 1.00 1.00
25.0-29.9 1.95 1.38, 2.76 <0.001 0.92 0.67, 1.25 0.59 1.12 0.85, 1.47 0.43 1.04 0.85, 1.28 0.67
≥ 30.0 2.05 1.40, 3.01 <0.001 1.72 1.27, 2.31 <0.001 1.34 0.99, 1.80 0.06 0.81 0.63, 1.05 0.11
M2: Adjusted
c
<18.5 0.43 0.10, 1.80 0.25 1.18 0.61, 2.27 0.62 1.30 0.73, 2.30 0.37 1.46 0.99, 2.16 0.06
18.5-24.9 (ref) 1.00 1.00 1.00 1.00
25.0-29.9 1.68 1.16, 2.41 0.01 0.81 0.59, 1.13 0.21 1.02 0.76, 1.37 0.90 0.98 0.79, 1.21 0.84
≥ 30.0 1.78 1.19, 2.66 0.01 1.49 1.09, 2.04 0.01 1.25 0.90, 1.72 0.18 0.76 0.58, 0.98 0.04
Models to assess mediation
M3: M2+ hypertensive disorders
of pregnancy
d
<18.5 0.63 0.14, 2.84 0.55 1.35 0.66, 2.76 0.41 1.31 0.74, 2.33 0.35 1.47 0.99, 2.17 0.06
18.5-24.9 (ref) 1.00 1.00 1.00 1.00
25.0-29.9 1.52 1.00, 2.33 0.05 0.73 0.52, 1.04 0.08 1.02 0.75, 1.37 0.91 0.97 0.78, 1.19 0.74
≥ 30.0 1.17 0.73, 1.87 0.53 1.12 0.79, 1.59 0.53 1.27 0.92, 1.75 0.15 0.76 0.58, 0.99 0.04
M4: M2+ chorioamnionitis
e
<18.5 0.42 0.10, 1.77 0.24 1.17 0.61, 2.26 0.63 1.48 0.81, 2.70 0.20 1.48 1.00, 2.19 0.05
18.5-24.9 (ref) 1.00 1.00 1.00 1.00
25.0-29.9 1.70 1.18, 2.45 0.01 0.81 0.59, 1.12 0.21 1.04 0.76, 1.42 0.82 0.98 0.79, 1.21 0.86
≥ 30.0 1.77 1.18, 2.64 0.01 1.49 1.09, 2.04 0.01 1.30 0.93, 1.83 0.13 0.76 0.58, 0.98 0.04
M5: M2+ gestational diabetes
f
<18.5 0.44 0.10, 1.82 0.26 1.22 0.63, 2.33 0.56 1.32 0.74, 2.34 0.34 1.48 1.00, 2.19 0.05
18.5-24.9 (ref) 1.00 1.00 1.00 1.00
25.0-29.9 1.64 1.14, 2.36 0.01 0.75 0.54, 1.04 0.09 0.99 0.73, 1.33 0.93 0.95 0.77, 1.18 0.64
≥ 30.0 1.68 1.12, 2.52 0.01 1.25 0.90, 1.74 0.18 1.16 0.84, 1.61 0.37 0.73 0.56, 0.95 0.02
Grand model
M6: M2+ hypertensive disorders of
pregnancy
d+ chorioamnionitis
e +
gestational diabetes
f
<18.5 0.63 0.14, 2.86 0.55 1.39 0.68, 2.82 0.36 1.52 0.83, 2.78 0.17 1.50 1.01, 2.22 0.04
18.5-24.9 (ref) 1.00 1.00 1.00 1.00
25.0-29.9 1.58 1.03, 2.42 0.04 0.69 0.49, 0.99 0.04 0.99 0.72, 1.37 0.98 0.94 0.76, 1.16 0.56
≥ 30.0 1.22 0.76, 1.98 0.41 1.01 0.70, 1.45 0.96 1.19 0.84, 1.69 0.33 0.73 0.56, 0.95 0.02
BMI = Body Mass Index; PTB = Preterm Birth.
aData from 189 mothers with early medically-induced PTBs, 277 mothers with late medically-induced PTBs, 320 mothers with early spontaneous PTBs, 610 mothers
with late spontaneous PTBs, and 3281 mothers with term births.
bMultinomial regression used to compare early and late medically-induced and spontaneous PTB with term birth (reference group).
cAdjusted model includes maternal age, race/ethnicity, marital status, income, education, child sex, maternal gestational weight gain, smoking, alcohol or illicit
drug use, stress, parity, cervical incompetence, and placenta previa.
dHypertensive disorders of pregnancy are categorized as chronic hypertension, mild preeclampsia, severe hypertensive disorders (severe preeclampsia, eclampsia,
HELLP syndrome), and none.
eChorioamnionitis is categorized as subclinical chorioamnionitis, clinical chorioamnionitis, and none.
fMaternal diabetes is categorized as gestational diabetes or diabetes prior to pregnancy vs. none.
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associated with a 1.6-fold (95% C.I. 1.23, 2.05) increased
odds of medically-induced PTB, but not spontaneous PTB
(OR 0.90 [95% C.I. 0.73, 1.12]), compared to term birth
(Table 2, Model 2). The association between prepregnancy
obesity and medically-induced PTB was largely attenuated
after adding hypertensive disorders of pregnancy (OR 1.59
to 1.13) and gestational diabetes (OR 1.59 to 1.40) to our
m o d e l( T a b l e2 ,M o d e l3a n d5 ) ,a n di no u r“grand” model
(OR 1.59 to 1.08) (Table 2, Model 6), which included all
mediators and covariates. We also found an increased
odds of spontaneous PTB among underweight mothers
in our adjusted model (1.40 [95% C.I. 0.99, 1.99]) (Table 2,
Model 2) and in our grand model (1.51 [95% C.I. 1.06,
2.15]) (Table 2, Model 6).
Finally, we examined early and late medically-induced
and early and late spontaneous PTB vs. term birth (Table 3).
Among medically-induced PTBs, we found that prepreg-
nancy obesity was associated with increased odds of early
(1.78 [1.19, 2.66]) and late 1.49 [1.09, 2.04]) PTB (Table 3,
Model 2). The relationships between prepregnancy obesity
and early and late medically-induced PTB were attenuated
with inclusion of hypertensive disorders of pregnancy (OR
1.78 to 1.17 for early and OR 1.49 to 1.12 for late PTB)
(Table 3, Model 2 and 3) and gestational diabetes (OR 1.78
to 1.68 for early and OR 1.49 to 1.25 for late PTB) (Table 3,
Model 2 and 5). Among spontaneous PTBs, we found no
associations between prepregnancy BMI and early spontan-
eous PTB, but we found associations between maternal
underweight and obesity and late spontaneous PTB in op-
posite directions. Maternal underweight was associated
with an increased odds (1.46 [0.99, 2.16]) of late spontan-
eous PTB and maternal obesity was associated with a de-
creased odds (0.76 [0.58, 0.98]) of late spontaneous PTB
(Table 3, Model 2). We additionally show the direction of
the associations of prepregnancy underweight and obesity
with early and late medically-induced and spontaneous
PTB with arrows in Table 4.
Finally, we performed a sensitivity analysis excluding
term, low birth weight (≤2,500 g) infants in our reference
group, as these infants were “cases” in the original case–
control study design of the Boston Birth Cohort. We found
similar results examining prepregnancy BMI with 2906
term, non-low birth weight (>2,500 g) “controls,” so we
show results without combined reference group of 3281
term infants.
Discussion
In this US inner-city study of mother-infant pairs, we found
that prepregnancy obesity was associated with a higher risk
of medically-induced PTB, both early (<34 weeks’gestation,
1.8-fold higher risk) and late (34–36 weeks’ gestation, 1.5-
fold higher risk). These associations were explained in
part by hypertensive disorders of pregnancy and less so by
gestational diabetes, common co-morbidities of obesity in
pregnancy that are also associated with medically-induced
PTB. In contrast, prepregnancy obesity was not associated
with early spontaneous PTB, and inversely associated with
late spontaneous PTB. We also found that prepregnancy
underweight was associated with higher risk of spontan-
eous late PTB.
While many studies have reported that maternal obesity
is a risk factor for PTB [9], fewer have separated medically-
induced from spontaneous PTB. Our findings agree with
other studies linking prepregnancy obesity with an in-
creased risk of medically-induced PTB [22-28]. We ex-
tended findings of prior studies by examining specific
reasons for medical induction. In our study, hypertensive
disorders of pregnancy and gestational diabetes largely ex-
plained the association of prepregnancy obesity with both
early and late medically induced PTB, suggesting that these
conditions may lie on the causal pathway between maternal
obesity and PTB. These results suggest that interventions
targeted at reducing severity of hypertensive disorders of
pregnancy and gestational diabetes may reduce risks of
medically-induced PTB among obese women.
In contrast to the more consistent evidence linking
prepregnancy obesity with medically-induced PTB, studies
of spontaneous PTB have yielded inconsistent results.
Among studies examining associations of prepregnancy
obesity and early spontaneous PTB, three reported higher
risk [24,26,27], one reported lower risk [25], whereas we
found no association. Among studies examining associa-
tions of prepregnancy obesity and late spontaneous PTB,
two reported higher risk [27,29], one reported no associ-
ation [24], whereas we found in our cohort a surprising
lower risk. Lack of consistency in findings could be due to
lack of adjustment by factors associated with PTB such as
gestational weight gain [25,26], smoking [25], or illicit drug
use [25], or due to inconsistent cut points of maternal BMI
to define obesity and gestational age to define “early” and
“late” PTB. For instance, we defined prepregnancy obesity
per Institute of Medicine Criteria [16] as BMI≥30.0 kg/m
2,
while others examined more granular BMI subgroups (i.e.
BMI 30.0-34.9 kg/m
2, 35.0-39.9 kg/m
2,a n d ≥40.0 kg/m
2)
[24,26]. It is possible that our null association of prepreg-
nancy obesity (a composite of all mothers with a prepreg-
nancy BMI ≥30.0 kg/m
2) and early spontaneous PTB, may
Table 4 Direction of associations between maternal
underweight and obesity and early and late
medically-induced and spontaneous PTB compared
to term births
Medically-induced PTB Spontaneous PTB
Early Late Early Late
Maternal underweight ── ─ ↑
Maternal obesity ↑↑ ─ ↓
─no association; ↑= increased odds; ↓ = decreased odds.
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among extremely obese women only. Furthermore, we de-
fined late preterm as infants born 34–36 weeks’ gestation
according to the American Academy of Pediatrics [30,31]
and American College of Obstetrics and Gynecology [31],
and combined all infants born <34 weeks gestation as
“early” PTB. Others defined later PTB subgroups as 35-37
[24] or 32-36 [29] weeks’ gestation. Inconsistent findings
among studies that use different gestational age cut points
suggest that different mechanisms of spontaneous PTB
may occur at various stages of gestation. Finally, it is pos-
sible that associations of maternal obesity and spontaneous
PTB are inconsistent because of variable clinical thresholds
for medical-induction. Obese women who are at risk for
spontaneous PTB may instead deliver following medical-
induction because of clinical concerns that differ by study
population, thus changing the remaining pool of women at
risk for spontaneous PTB.
Some authors [26,27] have hypothesized that chor-
ioamnionitis may be on the causal pathway between pre-
pregnancy obesity and PTB. We specifically addressed
this hypothesis by examining chorioamnionitis as a me-
diating factor between prepregnancy obesity and spon-
taneous PTB. However, we did not find higher risks of
spontaneous PTB among obese women, precluding the
ability to appreciate a mediating effect by chorioamnio-
nitis. Future studies that evaluate inflammatory markers,
other infectious conditions besides chorioamnionitis, or
additional factors associated with prepregnancy obesity,
are needed to further uncover mechanisms spontaneous
PTB among obese women. Because mechanisms of
spontaneous PTB may vary throughout pregnancy, a
continuum of gestational ages should be examined.
On the other end of the weight spectrum, numerous
studies have reported an increased risk of spontaneous
PTB among underweight women [13,22,24,25,27]. In our
study, maternal underweight was associated with a 1.5-
fold higher odds of late (but not early) spontaneous
PTB, independent of gestational weight gain. We specu-
late that poor maternal nutritional status in pregnancy is
particularly costly to the fetus during late pregnancy, a
period of rapid fetal growth and nutrient accretion. In
contrast, maternal underweight was not associated with
an increased risk for medically indicated PTB.
Strengths of this study include careful adjustment for
many known risk factors of PTB, including demographic
variables and maternal pregnancy conditions, including
gestational weight gain. Our study population was com-
posed of US, inner-city, predominantly low soceioeco-
nomic and minority mother-infant pairs enabling us to
examine associations of prepregnancy BMI and several
subtypes of PTB, as well as potential mediating factors,
among mothers with high risk of PTB. Our population
may not be generalizeable to others. Other limitations
include maternal self-report of weight and height to cal-
culate prepregnancy BMI. Under reporting of weight or
over reporting height may have lead to falsely decreased
BMI, as described in other studies [32], and may have
biased our analyses examining prepregnancy overweight
and obesity toward the null, and prepregnancy under-
weight away from the null.
Conclusion
We found that maternal obesity is associated with higher
risk of medically-induced but not spontaneous PTB, and
further, that hypertensive disorders of pregnancy and ges-
tational diabetes appear to largely explain this association.
Our findings suggest that intervention strategies targeted
at reducing severity or incidence of severe hypertensive
disorders and gestational diabetes among obese women
may, in turn, reduce medically-induced PTB. In contrast,
the relationship between maternal obesity and spontan-
eous PTB remains unclear. Future studies that examine
factors along the causal pathway between maternal obesity
and early and late spontaneous PTB subgroups are needed
to identify targets for intervention.
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